All stock lists
Unlock the score
Outlook Therapeutics, Inc. (NASDAQ:OTLK)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.51-0.01 (-1.16%)
Market cap
$125M
Insider Score
Health Score
Analyst consensus
Listed since
Jun 14, 2016
Website
Insider Score
/ 100
OTLK Insider Score
Outlook Therapeutics, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 2 insiders in the last 90 days.
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
OTLK Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New OTLK patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to OTLK from public contracts
Source: USAspending.gov
Recently reported changes in OTLK holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing OTLK, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| No congressional trades recorded for OTLK. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.